0001709401-22-000004.txt : 20220801 0001709401-22-000004.hdr.sgml : 20220801 20220801173845 ACCESSION NUMBER: 0001709401-22-000004 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220729 FILED AS OF DATE: 20220801 DATE AS OF CHANGE: 20220801 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Schaffert Susanne CENTRAL INDEX KEY: 0001938363 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38586 FILM NUMBER: 221126032 MAIL ADDRESS: STREET 1: C/O RUBIUS THERAPEUTICS, INC. STREET 2: 399 BINNEY STREET, SUITE 300 CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Rubius Therapeutics, Inc. CENTRAL INDEX KEY: 0001709401 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 042688109 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 399 BINNEY STREET, SUITE 300 CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-679-9600 MAIL ADDRESS: STREET 1: 399 BINNEY STREET, SUITE 300 CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 wf-form4_165938990864068.xml FORM 4 X0306 4 2022-07-29 0 0001709401 Rubius Therapeutics, Inc. RUBY 0001938363 Schaffert Susanne C/O RUBIUS THERAPEUTICS, INC. 399 BINNEY STREET, SUITE 300 CAMBRIDGE MA 02139 1 0 0 0 Stock Option (Right to Buy) 0.702 2022-07-29 4 A 0 50000 0 A 2032-07-28 Common Stock 50000.0 50000 D This option shall vest in equal quarterly installments over the twelve quarters following the grant date. /s/ Maiken Keson-Brookes, as Attorney-in-Fact 2022-08-01